Exosens Statistics

Total Valuation

Exosens has a market cap or net worth of GBP 1.48 billion. The enterprise value is 1.57 billion.

Market Cap	1.48B
Enterprise Value	1.57B

Important Dates

The next estimated earnings date is Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	30.73M

Valuation Ratios

The trailing PE ratio is 58.20.

PE Ratio	58.20
Forward PE	n/a
PS Ratio	4.53
PB Ratio	4.33
P/TBV Ratio	98.18
P/FCF Ratio	32.55
P/OCF Ratio	18.57
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.71, with an EV/FCF ratio of 34.64.

EV / Earnings	61.95
EV / Sales	4.66
EV / EBITDA	16.71
EV / EBIT	25.14
EV / FCF	34.64

Financial Position

The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.63.

Current Ratio	2.94
Quick Ratio	2.07
Debt / Equity	0.63
Debt / EBITDA	2.38
Debt / FCF	4.76
Interest Coverage	2.34

Financial Efficiency

Return on equity (ROE) is 9.96% and return on invested capital (ROIC) is 7.64%.

Return on Equity (ROE)	9.96%
Return on Assets (ROA)	6.20%
Return on Invested Capital (ROIC)	7.64%
Return on Capital Employed (ROCE)	10.30%
Revenue Per Employee	191,711
Profits Per Employee	14,934
Employee Count	1,700
Asset Turnover	0.53
Inventory Turnover	1.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	22.53
200-Day Moving Average	n/a
Relative Strength Index (RSI)	75.64
Average Volume (20 Days)	106,529

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Exosens had revenue of GBP 325.91 million and earned 25.39 million in profits.

Revenue	325.91M
Gross Profit	186.56M
Operating Income	60.45M
Pretax Income	34.57M
Net Income	25.39M
EBITDA	90.97M
EBIT	60.45M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 124.21 million in cash and 216.09 million in debt, giving a net cash position of -91.88 million.

Cash & Cash Equivalents	124.21M
Total Debt	216.09M
Net Cash	-91.88M
Net Cash Per Share	n/a
Equity (Book Value)	341.21M
Book Value Per Share	n/a
Working Capital	171.35M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 79.55 million and capital expenditures -34.15 million, giving a free cash flow of 45.40 million.

Operating Cash Flow	79.55M
Capital Expenditures	-34.15M
Free Cash Flow	45.40M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 57.24%, with operating and profit margins of 18.55% and 7.79%.

Gross Margin	57.24%
Operating Margin	18.55%
Pretax Margin	10.61%
Profit Margin	7.79%
EBITDA Margin	27.91%
EBIT Margin	18.55%
FCF Margin	13.93%

Dividends & Yields

Exosens does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.72%
FCF Yield	3.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a